We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+22.62%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.77B
AUM Growth
+$282M
Cap. Flow
+$179M
Cap. Flow %
10.07%
Top 10 Hldgs %
30.07%
Holding
2,442
New
714
Increased
405
Reduced
476
Closed
723

Sector Composition

Rank Sector Weight
1 Technology 7.8%
2 Healthcare 6.74%
3 Communication Services 5.4%
4 Consumer Discretionary 5.34%
5 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
726
Altria Group
MO
$109B
$186K 0.01%
3,245
-510
-14% -$26.1K
SBRA icon
727
Sabra Healthcare REIT
SBRA
$5.28B
$186K 0.01%
9,536
+4,106
+76% +$77.8K
SHW icon
728
Sherwin-Williams
SHW
$88.1B
$186K 0.01%
1,293
-7,584
-85% -$1.06M
BG icon
729
Bunge Global
BG
$21.6B
$185K 0.01%
3,487
-72,096
-95% -$3.83M
SLV icon
730
CALL
iShares Silver Trust
SLV
$32B
$184K 0.01%
+13,000
New +$190K
SIVB
731
DELISTED
SVB Financial Group
SIVB
$184K 0.01%
827
-590
-42% -$137K
UFS
732
DELISTED
DOMTAR CORPORATION (New)
UFS
$184K 0.01%
3,703
-427
-10% -$20.3K
AIRG icon
733
Airgain
AIRG
$71.7M
$183K 0.01%
14,272
+631
+5% +$7.41K
AMPH icon
734
Amphastar Pharmaceuticals
AMPH
$896M
$183K 0.01%
8,935
+5,388
+152% +$121K
PFF icon
735
iShares Preferred and Income Securities ETF
PFF
$13.2B
$183K 0.01%
5,000
-26,000
-84% -$934K
RWM icon
736
ProShares Short Russell2000
RWM
$101M
$183K 0.01%
4,500
CVX icon
737
Chevron
CVX
$382B
$182K 0.01%
1,480
-262
-15% -$31K
GWPH
738
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$182K 0.01%
1,079
-2,141
-66% -$319K
BRK.B icon
739
CALL
Berkshire Hathaway Class B
BRK.B
$1.14T
$181K 0.01%
+900
New +$182K
INDP icon
740
CALL
Indaptus Therapeutics
INDP
$159M
$181K 0.01%
11
-2
-15% -$35K
MAS icon
741
Masco
MAS
$14.7B
$181K 0.01%
4,600
+2,451
+114% +$87.4K
HUN icon
742
Huntsman Corp
HUN
$1.82B
$180K 0.01%
8,009
-16,133
-67% -$363K
LULU icon
743
PUT
lululemon athletica
LULU
$14.5B
$180K 0.01%
+1,100
New +$161K
REXR icon
744
Rexford Industrial Realty
REXR
$8.13B
$180K 0.01%
5,034
-1,027
-17% -$34.6K
GBDC icon
745
Golub Capital BDC
GBDC
$3.41B
$179K 0.01%
+10,210
New +$180K
SRPT icon
746
PUT
Sarepta Therapeutics
SRPT
$1.81B
$179K 0.01%
+1,500
New +$193K
GM icon
747
General Motors
GM
$77.2B
$178K 0.01%
4,811
-23,543
-83% -$894K
OSIR
748
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$177K 0.01%
+9,311
New +$151K
KMB icon
749
Kimberly-Clark
KMB
$35.9B
$176K 0.01%
1,420
-2,416
-63% -$281K
RWT
750
Redwood Trust
RWT
$574M
$176K 0.01%
+10,889
New +$172K

Similar funds

Prelude Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Prelude Capital Management held 2,442 positions worth $1.77B, up 19% from $1.49B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Prelude Capital Management deployed $179M of net new capital in Q1 2019, opening 714 new positions and adding to 405 existing holdings. Its largest new stake was Ultimate Software Group Inc: 57,473 shares worth $19M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Integrated Device Technology I, an estimated $12.7M trimmed.

  • Prelude Capital Management's largest Q1 2019 buy was Ultimate Software Group Inc: 57,473 shares worth $19M.
  • Prelude Capital Management added most to Celgene Corp in Q1 2019, an estimated $43.9M increase.
  • Prelude Capital Management's biggest Q1 2019 reduction was Integrated Device Technology I, cutting an estimated $12.7M.
  • Prelude Capital Management fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $47.3M.
  • Prelude Capital Management's ten largest holdings make up 30% of its $1.77B portfolio in Q1 2019.
  • Prelude Capital Management opened 714 new positions and closed 723 in Q1 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $1.77B.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.